Chronic small vessel disease
Chronic small vessel disease, also known as leukoaraiosis, is a radiological term used to describe diffuse white matter changes thought to be related to small vessel disease.
Terminology
There is no consensus in the literature regarding terminology for Chronic small vessel disease/leukoaraiosis. These terms are often used interchangeably with variations along the lines of small vessel chronic ischemia, microvascular ischemia, ischemic microangiopathy, age-related white matter changes, and unidentified bright objects.
Epidemiology
Chronic small vessel disease is more common with increasing age. The prevalence of white matter lesions in the general population is reported to be between 39 to 96% .
Clinical presentation
Chronic small vessel disease is often an incidental asymptomatic finding on imaging. However, it has been shown to cause vascular dementia and it is more common in patients with dementia (vascular dementia, Alzheimer disease, Lewy body dementia) compared to the general population (100% v. 92% respectively in one study) .
Pathology
Histology from these lesions show atrophy of axons and decreased myelin. The pathophysiology of white matter lesions is different depending on the area of involvement, i.e. periventricular or deep (subcortical) white matter. This difference is emphasized in the Fazekas scale in which the two are separated. Pathogenesis and especially its clinical significance are still incompletely understood .
Periventricular white matter lesions
Periventricular white matter changes (3-13 mm from the ventricular surface) are thought to be haemodynamically determined rather than only related to small vessel disease . This region is a vascular border zone vascularized by non-collateralising ventriculofugal vessels arising from subependymal arteries. As such, it is prone to local and systemic decrease in cerebral blood flow. It is a predictor of watershed infarcts especially when located along the posterior horns and it is correlated with carotid artery stenosis .
It is worth noting that juxtaventricular white matter changes (<3 mm from the ventricular surface), such as ependymitis granularis, are not related to small vessel disease, but rather represent cerebrospinal fluid leak due to disruption of the ependyma .
Deep and subcortical white matter lesions
Deep white matter changes (>13 mm from the ventricular surface, <4 mm from the corticomedullary junction) are thought to be caused by lipohyalinosis (small vessel disease), i.e. incomplete arteriosclerosis . They are a predictor of lacunar infarcts.
Radiographic features
Chronic small vessel disease consists of bilateral patchy or diffuse white matter changes often observed on imaging studies . The Fazekas scale has been proposed to quantify white matter lesions related to leukoaraiosis. This is especially useful in the setting of dementia.
CT
- non-enhancing white matter hypodensities
MRI
- T1: hypointense or isointense, less conspicuous than on T2/FLAIR
- T2/FLAIR: hyperintense
- DWI: no diffusion restriction
- T1 C+ (Gd): non-enhancing
History and etymology
The term leukoaraiosis means white matter rarefaction and comes from the Greek (leuko = white and araios = rarefaction). It was first proposed by Vladimir Hachinski (fl 2019) a Ukrainian-born Canadian neurologist .
Differential diagnosis
The differential diagnosis is wide and includes multiple diseases involving the white matter, including:
Siehe auch:
- Fazekas-Skala
- Demyelinisierende Erkrankung
- CADASIL
- multi-infarct dementia
- radiologically isolated syndrome
- subcortical arteriosclerotic encephalopathy (SAE)
- Leukenzephalopathie
- periventrikuläres Marklager SAE
- Demyelinisation
- CNS white matter confluent lesions
- MAGNIMS consensus on MRI diagnosis of multiple sclerosis
- toxische Enzephalopathie
- McDonald diagnostic criteria 2010